Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0000899243-16-024798

Chief Financial Officer acquired 1,925 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Viret Jean-Frederic Chief Financial Officer 2016-07-06 Option exercise +1,925 $13.50 $25,988 2,325 D
Derivatives
Viret Jean-Frederic Chief Financial Officer 2016-07-06 Option exercise · Stock Option (Right to Buy) −1,925 132,648 D
Loading xslF345X03/doc4.xml…